TopNews

Roche's phase III IMmotion151 study of Tecentriq & Avastin to treat advanced/metastatic RCC meets co-primary endpoint

KPRDO urges govt to withdraw MDR on UPI transactions as it will be a huge burden on pharma traders

Nandita Vijayasimha, Bengaluru

Wednesday, September 30, 2026, 08:00 Hrs [IST]

The Karnataka Pharma Retailers & Distributors Organization (KPRDO) has urged Union Finance Minister Nirmala Sitharaman to withdraw the proposed 0.4% merchant discount rate (MDR) on specified Unified

To access the full article, please log in or subscribe.

Pharma Services

Tenders & Projects

Tenders & Enquires Pharma Projects

Corporate

Company Profile Corporate Results Corporate X-ray Pharmabiz Studies of Top Companies

US FDA Update

US FDA: ANDA US FDA: Warnings US FDA: Approved NMEs US FDA: Approved NMEs US FDA: REFUSAL

Export & Import

Drug Export Procedures Drug Units With WHO GMP Certification Pharma Export Data Import Reg. Update

Pharma Laws & Documents

Notifications Pharma Regulations Patent Laws and Amendments Patent Scan Documents New Drug Approvals Notified Prices

Labs & Govt Bodies

Govt Recognised In-House R&D Units AICTE Boards & Committees List of Indian CROs List of CROs (International) Govt & approved labs of India List of State Drugs Controllers